All lobbying filings

ARENTFOX SCHIFF LLP

ARENTFOX SCHIFF LLP filed a Q2 report for TRANSPARENCY-RX CORP. on July 21, 2025, reporting $20,000 in lobbying income.

Lobbying for TRANSPARENCY-RX CORP. · Coalition of licensed transparent pharmacy benefit managers

All filings by ARENTFOX SCHIFF LLP · Everything TRANSPARENCY-RX CORP. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Income

$20,000

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Pharmacy Benefit Manager reform Transparency in prescription drug markets Prescription drug prices S. 891 (Bipartisan Health Care Act), regarding Pharmacy Benefit Manager reform, transparency in prescription drug markets, and prescription drug prices

Bills named in this filing 1

S. 891
Bipartisan Health Care Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.